Improving diagnosis, prevention, and treatment of tuberculosis
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)
The UCSF-UCB Tuberculosis Research Advancement Center is working to improve how we understand, diagnose, prevent, and treat tuberculosis, and they're inviting both new and experienced researchers to join in this important effort.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11105877 on NIH RePORTER |
What this research studies
The UCSF-UCB Tuberculosis Research Advancement Center (TRAC) aims to enhance our understanding of tuberculosis (TB) and develop new tools for its diagnosis, prevention, and treatment. This initiative involves collaboration across various disciplines and utilizes advanced technologies to tackle the complexities of the TB epidemic. The center will support new researchers in the field through mentorship and funding, while also encouraging non-TB researchers to contribute to TB research. By integrating multiple research cores, the center seeks to foster innovation and collaboration in TB studies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of tuberculosis or those currently affected by the disease.
Not a fit: Patients with conditions unrelated to tuberculosis or those who are not at risk for TB may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in TB diagnosis, prevention, and treatment, ultimately reducing the burden of the disease.
How similar studies have performed: Previous research initiatives focused on tuberculosis have shown promise in improving treatment and diagnostic methods, indicating that this approach is building on established successes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Nahid, Payam — University of California, San Francisco
- Study coordinator: Nahid, Payam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.